APO RESEARCH · REPORT
Traveler's Diarrhea Therapeutics
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
Product & engineering
Understand the product.
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
Selected research
Industry Research
Traveler's Diarrhea Therapeutics Industry Research Report 2026
Market perspective
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
North America is the largest Traveler's Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.
Report Scope
Read the full market overview
This report quantifies the global Traveler's Diarrhea Therapeutics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Traveler's Diarrhea Therapeutics Market by Company
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
Traveler's Diarrhea Therapeutics Segment by Type
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Others
Traveler's Diarrhea Therapeutics Segment by Application
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
Traveler's Diarrhea Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Traveler's Diarrhea Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Traveler's Diarrhea Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Traveler's Diarrhea Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Traveler's Diarrhea Therapeutics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Traveler's Diarrhea Therapeutics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Traveler's Diarrhea Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Immunization
- Non-antibiotic Agents
- Antibiotics
- Anti-Motility Agents
- Others
Applications
- Adult Traveler's Diarrhea
- Children Traveler's Diarrhea
Companies covered
- Salix Pharmaceuticals
- P&G
- Johnson & Johnson
- Otsuka Pharma
- Valneva
- Shanghai United Cell
- PaxVax
- Livzon
- Immuron
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Traveler's Diarrhea Therapeutics Market Size (2021-2032)
- 2.2.2 Global Traveler's Diarrhea Therapeutics Sales (2021-2032)
- 2.2.3 Global Traveler's Diarrhea Therapeutics Market Average Price (2021-2032)
- 2.3 Traveler's Diarrhea Therapeutics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Immunization
- 2.3.3 Non-antibiotic Agents
- 2.3.4 Antibiotics
- 2.3.5 Anti-Motility Agents
- 2.3.6 Others
- 2.4 Traveler's Diarrhea Therapeutics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult Traveler's Diarrhea
- 2.4.3 Children Traveler's Diarrhea
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Traveler's Diarrhea Therapeutics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Traveler's Diarrhea Therapeutics Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Traveler's Diarrhea Therapeutics Revenue of Manufacturers (2021-2026)
- 3.4 Global Traveler's Diarrhea Therapeutics Average Price by Manufacturers (2021-2026)
- 3.5 Global Traveler's Diarrhea Therapeutics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Traveler's Diarrhea Therapeutics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Traveler's Diarrhea Therapeutics, Product Type & Application
- 3.8 Global Manufacturers of Traveler's Diarrhea Therapeutics, Established Date
- 3.9 Global Traveler's Diarrhea Therapeutics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Salix Pharmaceuticals
- 4.1.1 Salix Pharmaceuticals Company Information
- 4.1.2 Salix Pharmaceuticals Business Overview
- 4.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Portfolio
- 4.1.5 Salix Pharmaceuticals Recent Developments
- 4.2 P&G
- 4.2.1 P&G Company Information
- 4.2.2 P&G Business Overview
- 4.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 P&G Traveler's Diarrhea Therapeutics Product Portfolio
- 4.2.5 P&G Recent Developments
- 4.3 Johnson & Johnson
- 4.3.1 Johnson & Johnson Company Information
- 4.3.2 Johnson & Johnson Business Overview
- 4.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolio
- 4.3.5 Johnson & Johnson Recent Developments
- 4.4 Otsuka Pharma
- 4.4.1 Otsuka Pharma Company Information
- 4.4.2 Otsuka Pharma Business Overview
- 4.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolio
- 4.4.5 Otsuka Pharma Recent Developments
- 4.5 Valneva
- 4.5.1 Valneva Company Information
- 4.5.2 Valneva Business Overview
- 4.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Valneva Traveler's Diarrhea Therapeutics Product Portfolio
- 4.5.5 Valneva Recent Developments
- 4.6 Shanghai United Cell
- 4.6.1 Shanghai United Cell Company Information
- 4.6.2 Shanghai United Cell Business Overview
- 4.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolio
- 4.6.5 Shanghai United Cell Recent Developments
- 4.7 PaxVax
- 4.7.1 PaxVax Company Information
- 4.7.2 PaxVax Business Overview
- 4.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 PaxVax Traveler's Diarrhea Therapeutics Product Portfolio
- 4.7.5 PaxVax Recent Developments
- 4.8 Livzon
- 4.8.1 Livzon Company Information
- 4.8.2 Livzon Business Overview
- 4.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Livzon Traveler's Diarrhea Therapeutics Product Portfolio
- 4.8.5 Livzon Recent Developments
- 4.9 Immuron
- 4.9.1 Immuron Company Information
- 4.9.2 Immuron Business Overview
- 4.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Immuron Traveler's Diarrhea Therapeutics Product Portfolio
- 4.9.5 Immuron Recent Developments
5 Global Traveler's Diarrhea Therapeutics Market Scenario by Region
- 5.1 Global Traveler's Diarrhea Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Traveler's Diarrhea Therapeutics Sales by Region: 2021-2032
- 5.2.1 Global Traveler's Diarrhea Therapeutics Sales by Region: 2021-2026
- 5.2.2 Global Traveler's Diarrhea Therapeutics Sales by Region: 2027-2032
- 5.3 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2021-2032
- 5.3.1 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2021-2026
- 5.3.2 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2027-2032
- 5.4 North America Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
- 5.4.1 North America Traveler's Diarrhea Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Traveler's Diarrhea Therapeutics Sales by Country (2021-2032)
- 5.4.3 North America Traveler's Diarrhea Therapeutics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
- 5.5.1 Europe Traveler's Diarrhea Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Traveler's Diarrhea Therapeutics Sales by Country (2021-2032)
- 5.5.3 Europe Traveler's Diarrhea Therapeutics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Traveler's Diarrhea Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Traveler's Diarrhea Therapeutics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
- 5.7.1 South America Traveler's Diarrhea Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Traveler's Diarrhea Therapeutics Sales by Country (2021-2032)
- 5.7.3 South America Traveler's Diarrhea Therapeutics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Traveler's Diarrhea Therapeutics Sales by Type (2021-2032)
- 6.1.1 Global Traveler's Diarrhea Therapeutics Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2021-2032)
- 6.2 Global Traveler's Diarrhea Therapeutics Revenue by Type (2021-2032)
- 6.2.1 Global Traveler's Diarrhea Therapeutics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2021-2032)
- 6.3 Global Traveler's Diarrhea Therapeutics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Traveler's Diarrhea Therapeutics Sales by Application (2021-2032)
- 7.1.1 Global Traveler's Diarrhea Therapeutics Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2021-2032)
- 7.2 Global Traveler's Diarrhea Therapeutics Revenue by Application (2021-2032)
- 7.2.1 Global Traveler's Diarrhea Therapeutics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2021-2032)
- 7.3 Global Traveler's Diarrhea Therapeutics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Traveler's Diarrhea Therapeutics Value Chain Analysis
- 8.1.1 Traveler's Diarrhea Therapeutics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Traveler's Diarrhea Therapeutics Production Mode & Process
- 8.2 Traveler's Diarrhea Therapeutics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Traveler's Diarrhea Therapeutics Distributors
- 8.2.3 Traveler's Diarrhea Therapeutics Customers
9 Global Traveler's Diarrhea Therapeutics Analyzing Market Dynamics
- 9.1 Traveler's Diarrhea Therapeutics Industry Trends
- 9.2 Traveler's Diarrhea Therapeutics Industry Drivers
- 9.3 Traveler's Diarrhea Therapeutics Industry Opportunities and Challenges
- 9.4 Traveler's Diarrhea Therapeutics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst